Alexandra Garcilazo-Reyes

2 articles listing Alexandra Garcilazo-Reyes in Nature Communications, indexed by Paperzzz from Crossref and OSF.

1. Author Correction: Alectinib in combination with bevacizumab as first-line treatment in ALK-rearranged non-small cell lung cancer (ALEK-B): a single-arm, phase 2 trial Nature Communications
2. Alectinib in combination with bevacizumab as first-line treatment in ALK-rearranged non-small cell lung cancer (ALEK-B): a single-arm, phase 2 trial Nature Communications